Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.
Press releases published on September 3, 2025
Atico Announces Completion of The Environmental Consultation Process at La Plata Project
VANCOUVER, British Columbia, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTCQX: ATCMF) is pleased to announce that the Ministry of the Environment, Water, and Ecological Transition (MAATE) …
New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression
SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies1 that …
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
– Expands Avadel’s pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia – – Initial pharmacokinetic (PK) and comparative bioavailability study to initiate in fourth quarter 2025 …
374Water Announces Open-Market Purchases of Company Stock by Board Members and Senior Management
DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader in organic waste destruction technology and services for the municipal, federal, and industrial markets, today announced recent …
Surrozen to Present at Upcoming Healthcare Investor Conference
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye …
Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2
WARREN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the continuing need for SARS-CoV-2 treatments for individuals with weakened immune systems, who are at the highest risk of …
Rail Vision Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
Ra’anana, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today announced that it has received a …
Radiance Biopharma Signs Exclusive License For ‘First In Class’ c-Met/EGFR Targeted Nano Antibody ADC
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or "Company"), a clinical-stage biotechnology company, announced that it has signed an Exclusive License Agreement with Novatim Immune Therapeutics (Zhejiang) CO., LTD. , (“ …
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Asure Software Sets September 2025 Investor Conference Schedule
AUSTIN, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (“HCM”) software solutions, is scheduled to participate at the following financial conferences during …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
MOG Digitech Holdings Limited (1942.HK) Makes Strategic Investment in ALT5, Partners with WLFI to Advance Stablecoin and DeFi Ecosystem
Hong Kong, China, Sept. 03, 2025 (GLOBE NEWSWIRE) -- On August 25, MOG Digitech Holdings Limited (1942.HK)(“MOG Digitech”) announced a strategic investment of USD 500,000 in ALT5 Sigma Corporation (NASDAQ: ALTS) (“ALT5”), indirectly through the …
XLM News: Introducing StellarPad AI, Stellar Blockchain's First-Ever Non-Custodial AI Launchpad
HAMILTON, New Zealand, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Stellar Lumens (XLM) community is about to experience a groundbreaking shift as the highly-anticipated StellarPad AI introduces itself to the crypto community. Defined as "The First Non- …
American Botanical Council Debuts Saw Palmetto Educational Video on HerbTV
Austin, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The nonprofit American Botanical Council (ABC) announces the premiere of its new educational video, “Saw Palmetto: Safe and Effective Herb for Prostate and Men’s Urinary Health.” The video is available on …
iDox.ai Launches Comprehensive Redaction Suite for Automated Data Protection
Fremont, California, Sept. 03, 2025 (GLOBE NEWSWIRE) -- iDox.ai, a leader in AI-driven document compliance solutions, today announced the launch of its Redaction Suite, a complete platform designed to automate and streamline the redaction of sensitive …
Lumenix et le centre universitaire de santé McGill travaillent de concert pour rehausser la sécurité des patients et du personnel de soutien par l’entremise d’une technologie de plateforme d’IA perception-action ambiantes
OTTAWA, Ontario, 03 sept. 2025 (GLOBE NEWSWIRE) -- Lumenix annonce aujourd’hui un accord de collaboration pluriannuel pour le déploiement de la plateforme technologique AIMS (Artificially Intelligent Monitoring System) au Centre universitaire de santé …